TRxADE HEALTH, Inc. (NASDAQ:MEDS) Short Interest Down 35.1% in August

TRxADE HEALTH, Inc. (NASDAQ:MEDS) saw a significant decrease in short interest in the month of August. As of August 31st, there was short interest totalling 15,000 shares, a decrease of 35.1% from the August 15th total of 23,100 shares. Approximately 1.9% of the company’s stock are short sold. Based on an average daily trading volume, of 151,500 shares, the short-interest ratio is presently 0.1 days.

TRxADE HEALTH Price Performance

Shares of NASDAQ MEDS traded up $0.04 on Monday, hitting $7.37. The company had a trading volume of 12,555 shares, compared to its average volume of 212,095. TRxADE HEALTH has a 12-month low of $3.69 and a 12-month high of $44.56. The business has a 50 day moving average of $10.24 and a two-hundred day moving average of $10.37.

TRxADE HEALTH (NASDAQ:MEDS) last issued its quarterly earnings data on Friday, August 9th. The company reported ($1.04) earnings per share for the quarter. TRxADE HEALTH had a negative net margin of 149.81% and a negative return on equity of 196.79%. The business had revenue of $0.02 million for the quarter.

TRxADE HEALTH Cuts Dividend

The firm also recently announced a dividend, which was paid on Wednesday, July 24th. Shareholders of record on Friday, July 19th were given a $1.50 dividend. The ex-dividend date of this dividend was Friday, July 19th.

Hedge Funds Weigh In On TRxADE HEALTH

A hedge fund recently bought a new stake in TRxADE HEALTH stock. Virtu Financial LLC purchased a new stake in TRxADE HEALTH, Inc. (NASDAQ:MEDS) in the first quarter, according to its most recent filing with the SEC. The fund purchased 10,617 shares of the company’s stock, valued at approximately $109,000. Virtu Financial LLC owned about 0.75% of TRxADE HEALTH at the end of the most recent quarter. 5.68% of the stock is currently owned by hedge funds and other institutional investors.

About TRxADE HEALTH

TRxADE HEALTH, Inc operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace.